It is currently known that survival and recurrence post-LT are affected by tumor characteristics such as tumor size, tumor number, differentiation, vascular invasion, lymph node metastasis, and pre-LT serum AFP levels [14], [18], [19]. The gene discussed is AFP; the disease is neoplasm.